215 related articles for article (PubMed ID: 24857113)
1. Management of vulvar and vaginal melanomas: current and future strategies.
Leitao MM
Am Soc Clin Oncol Educ Book; 2014; ():e277-81. PubMed ID: 24857113
[TBL] [Abstract][Full Text] [Related]
2. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
[TBL] [Abstract][Full Text] [Related]
3. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
[TBL] [Abstract][Full Text] [Related]
4. Comparison of molecular abnormalities in vulvar and vaginal melanomas.
Aulmann S; Sinn HP; Penzel R; Gilks CB; Schott S; Hassel JC; Schmidt D; Kommoss F; Schirmacher P; Kommoss S
Mod Pathol; 2014 Oct; 27(10):1386-93. PubMed ID: 24603591
[TBL] [Abstract][Full Text] [Related]
5. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
[TBL] [Abstract][Full Text] [Related]
6. The role of sentinel lymph node mapping in lower genital tract melanoma.
Lopez S; Guerrisi R; Brusadelli C; Bogani G; Ditto A; Raspagliesi F
Minerva Ginecol; 2020 Dec; 72(6):384-390. PubMed ID: 32744452
[TBL] [Abstract][Full Text] [Related]
7. Vulvar and vaginal melanoma. A clinicopathologic study.
Heller DS; Moomjy M; Koulos J; Smith D
J Reprod Med; 1994 Dec; 39(12):945-8. PubMed ID: 7884749
[TBL] [Abstract][Full Text] [Related]
8. Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.
Leitao MM; Cheng X; Hamilton AL; Siddiqui NA; Jurgenliemk-Schulz I; Mahner S; Åvall-Lundqvist E; Kim K; Freyer G
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S117-22. PubMed ID: 24987924
[TBL] [Abstract][Full Text] [Related]
9. [Vulvar melanoma].
Chokoeva A; Tchernev G; Wollina U
Akush Ginekol (Sofiia); 2015; 54(2):56-60. PubMed ID: 25909143
[TBL] [Abstract][Full Text] [Related]
10. [Melanomas of the female genital tract: state of the art].
Trone JC; Guy JB; Mery B; Langrand Escure J; Lahmar R; Moncharmont C; Rivoirard R; Semay T; Chauleur C; Collard O; Vignot S; Magné N
Bull Cancer; 2014 Jan; 101(1):102-6. PubMed ID: 24445910
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.
Shoushtari AN; Bluth MJ; Goldman DA; Bitas C; Lefkowitz RA; Postow MA; Munhoz RR; Buchar G; Hester RH; Romero JA; Fitzpatrick LJ; Weiser MR; Panageas KS; Wolchok JD; Chapman PB; Carvajal RD
Melanoma Res; 2017 Feb; 27(1):57-64. PubMed ID: 27792058
[TBL] [Abstract][Full Text] [Related]
12. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site.
Zarei S; Voss JS; Jin L; Jenkins SM; Bryce AH; Erickson LA; Bell DA; Kipp BR; Flotte TJ
Int J Gynecol Pathol; 2020 Nov; 39(6):587-594. PubMed ID: 31567539
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutations might be more common than supposed in vulvar melanomas.
Wylomanski S; Denis MG; Théoleyre S; Bouquin R; Vallée A; Knol AC; Saint-Jean M; Peuvrel L; Dréno B; Quéreux G
Exp Dermatol; 2018 Feb; 27(2):210-213. PubMed ID: 29178146
[TBL] [Abstract][Full Text] [Related]
14. Melanomas of the vulva and vagina.
Skovsted S; Nielsen K; Blaakær J
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260594
[TBL] [Abstract][Full Text] [Related]
15. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
[TBL] [Abstract][Full Text] [Related]
16. Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature.
Boer FL; Ten Eikelder MLG; Kapiteijn EH; Creutzberg CL; Galaal K; van Poelgeest MIE
Cancer Treat Rev; 2019 Feb; 73():91-103. PubMed ID: 30685613
[TBL] [Abstract][Full Text] [Related]
17. Mucosal melanoma: pathogenesis, clinical behavior, and management.
Postow MA; Hamid O; Carvajal RD
Curr Oncol Rep; 2012 Oct; 14(5):441-8. PubMed ID: 22661391
[TBL] [Abstract][Full Text] [Related]
18. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Kalinsky K; Lee S; Rubin KM; Lawrence DP; Iafrarte AJ; Borger DR; Margolin KA; Leitao MM; Tarhini AA; Koon HB; Pecora AL; Jaslowski AJ; Cohen GI; Kuzel TM; Lao CD; Kirkwood JM
Cancer; 2017 Jul; 123(14):2688-2697. PubMed ID: 28334439
[TBL] [Abstract][Full Text] [Related]
19. [Melanoma in gynecology].
Musfeld D; De Grandi P
Geburtshilfe Frauenheilkd; 1986 Dec; 46(12):857-62. PubMed ID: 3817407
[TBL] [Abstract][Full Text] [Related]
20. Vulvar and vaginal melanomas: A retrospective study spanning 19 years from a tertiary center.
Joste M; Dion L; Brousse S; Nyangoh Timoh K; Rousseau C; Reilhac A; Laviolle B; Lesimple T; Lavoue V; Leveque J
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102091. PubMed ID: 33592345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
